GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AgeX Therapeutics Inc (STU:0X40) » Definitions » 12-1 Month Momentum %

AgeX Therapeutics (STU:0X40) 12-1 Month Momentum % : -43.39% (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AgeX Therapeutics 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-23), AgeX Therapeutics's 12-1 Month Momentum % is -43.39%.

The industry rank for AgeX Therapeutics's 12-1 Month Momentum % or its related term are showing as below:

STU:0X40's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -21.37 vs STU:0X40: -43.39

Competitive Comparison of AgeX Therapeutics's 12-1 Month Momentum %

For the Biotechnology subindustry, AgeX Therapeutics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AgeX Therapeutics's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AgeX Therapeutics's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where AgeX Therapeutics's 12-1 Month Momentum % falls into.



AgeX Therapeutics  (STU:0X40) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AgeX Therapeutics  (STU:0X40) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


AgeX Therapeutics 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of AgeX Therapeutics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


AgeX Therapeutics (STU:0X40) Business Description

Traded in Other Exchanges
N/A
Address
1101 Marina Village Parkway, Suite 201, Alameda, CA, USA, 94501
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

AgeX Therapeutics (STU:0X40) Headlines

No Headlines